Table 1. Previously reported biological attributes of the different part of Mikania micrantha plant.
Biological activity |
Plant parts |
Effective doses |
Targets |
Nature of actions |
Class of compounds |
Compounds |
Ref |
Anticancer |
Leaf |
500-1000 mg/kg BWa |
Ehrlich ascites carcinoma (EAC) cells in Swiss albino mice |
Arresting the tumor growth; Decreasing the volume and weight of tumor as well as the viable tumor cell count |
Flavonoids and saponins |
- |
[42] |
167.16–98.07 μg/ml 196.27–131.56 μg/ml |
K562 cell line; and HeLa cell lines |
Inducing apoptosis in both K562 and HeLa cells with reduction in tumor weight |
Flavonoids |
- |
[43] |
||
Whole plant |
20 μg/ml |
HL-60 cell line |
Apoptosis in HL-60 cell line and reducing cell viability vigorously |
- |
- |
[74] |
|
Aerial parts |
- |
CNS glia, breast, and lung tumor cells |
Antiproliferative activity against three cancer cell lines mediated by specific structural feature of the phytochemicals |
Sesquiterpene lactones |
Mikanolides, miscandenine, achalensolide, xerantholide, micrantholides, and 8-epi-mikanokryptin |
[3] |
|
Anti bacterial |
Whole plant |
200 mg/ml |
B. subtilis MTCC441, B. cereus MTCC430, S. aureus MTCC96, E. coli MTCC739, P. aeruginosa MTCC1688, and S. epidermidis MTCC435 |
Inhibited both gram positive and negative strains with similar potency |
Alkaloids, phenolics, tannins, steroids, and glycosides
|
- |
[19] |
20 µl |
P. aeruginosa, S. typhii, S. aureus, and S. pneumoniae |
Inhibited both gram positive and gram negative bacteria |
Tannins, polyphenols, alkaloids, saponins, and triterpenoids |
- |
[74] |
||
300 μg/disc |
S. aureus, B. cereus, E. coli, and S. sonnii |
Mild to moderate inhibitory activity against four bacteria |
- |
- |
[14] |
||
Leaf and Flower |
500 μg/ml (MIC)b 1000 μg/ml (MBC)c |
S. aureus MTCC1927, and S. pyogenes MTCC3160 |
Moderate inhibitory potency against both bacteria |
- |
- |
[2] |
|
Leaf |
- |
S. epidermis ATCC12228 |
Significant inhibitory activity against S. epidermis |
Alkaloids, flavonoids, and tannins |
- |
[22] |
|
62.5-125 mg/l (MIC) 125-250 mg/l (MBC) |
S. aureus, B. subtilis, M. luteus, B. cereus, R. solanacearum, X. oryzae pv. oryzae, X. campestris pv. vesicatoria, and X. campestris pv. citri |
Antibacterial effect against all bacterial isolates |
Sesquiterpene lactones |
Deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, dihydromikanolide, and m-methoxy benzoic acid |
[5] |
||
Stem, Leaf, Inflorescence |
0.5 – 4.0 μg/μl (MIC) |
B. subtilis ATCC6633, and E. coli ATCC6051 |
Both strains were sensitive to all three plant extracts |
- |
- |
[21] |
|
Antifungal |
Leaf |
21.44-53.18 mg/l (IC50)d |
E. turcicum, C. lagenarium, P. cubensis, and B. cinerea |
Inhibition of spore germination of fungal species |
Sesquiterpene lactones |
Deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, dihydromikanolide, and m-methoxy benzoic acid |
[5] |
Aerial parts |
0.5-2.0 mg/ml |
E. floccosum var. nigricans, M. canis, M. gypseum, and T. rubrum |
Completely inhibited the growth of tested fungi |
- |
- |
[2] |
|
Whole plant |
- |
F. moniliforme, F. eridiforme, F. proliferatum, and S. rolfsii |
Different extracts varied in antifungal activities; methanol extract showed good inhibitory activity against F. moniliforme and F. proliferatum |
Glycosides, and quinones |
- |
[29] |
|
Anti- parasitic |
Aerial parts |
- |
T. cruzi (epimastigotes), and L. braziliensis (promastigotes) |
Significant antiprotozoal activity was found for organic extract while aqueous extract showed low to moderate activity |
Sesquiterpene lactones |
Mikanolide, deoxymikanolide, dihydromikanolide, and scandenolide |
[35] |
Leaf |
50 mg/ml |
P. posthuma |
Paralysis and death of adult earthworm |
Alkaloids, flavonoids, saponins, phenolics, and tannins |
- |
[36] |
|
Anti-inflammatory |
Leaf |
200 mg/kg BW |
Carrageenan-induced rat paw edema |
Inhibition of acute and sub-acute inflammation |
- |
- |
[39] |
Whole plant |
- |
Human erythrocytes |
Inhibition of inflammation at concentration dependent manner |
Terpenoids and tannins
|
- |
[14] |
|
Aerial parts |
1 μM |
Mouse ear model edema induced by tetradecanoylphorbol acetate (TPA) |
Inhibition of ear inflammation |
Sesquiterpene lactones |
15-O-4′-hydroxy-methacryl-micrantholide, 15-O-4′-hydroxymethacryl-14-acetoxy-micrantholide, 15-O-3′-chloro-2′- hydroxy-isobutyryl-micrantholide, and 15-O-2′-hydroxyisobutyryl- micrantholide |
[3] |
|
Stem, Leaf Inflorescence |
1 mg/ear |
TPA-induced male mice ear edema |
Significantly inhibited ear inflammation in mice |
- |
- |
[21] |
|
Anti- diabetic |
Leaf |
150 mg/kg BW 200 mg/kg BW |
Alloxan-induced diabetic male Spargue Dawley rats |
Reduction of blood glucose level after 20 days |
- |
- |
[48, 49] |
Anti- oxidant |
Aerial parts |
16.24–21.67 μM (EC50)e |
2,2-diphenyl-2-picrylhydrazyl (2,2-DPPH) |
DPPH radical scavenging activity |
Phenolic compounds |
(+)-isolariciresinol, caffeic acid, ethyl protocatechuate, and protocatechuic aldehyde |
[54] |
Leaf |
41.8 μg/ml (IC50) |
1,1-DPPH |
DPPH radical scavenging activity |
Alkaloids, flavonoids, saponins, phenolic compounds and tannins |
- |
[36, 53] |
|
Wound healing |
Whole plant |
|
Male Wistar strain albino rats |
Moderate wound healing activity |
- |
- |
[59] |
Leaf |
7 μg/ml and 15 μg/ml |
BJ cell line (human fibroblast), Rats |
Wound healing significantly accelerated at lower concentrations; and Improving the percentage of wound contraction |
- |
- |
[48, 57] |
aBW stands for bodyweight; bMIC denotes the minimum inhibitory concentration; cMBC is the minimum bactericidal concentration; dIC50 defines the concentration of an extract needed for 50% inhibition in vitro; and eEC50 is the concentration of a drug that provides half-maximal response.